Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank73
3Y CAGR-4.2%
5Y CAGR+30.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-4.2%/yr
vs +50.5%/yr prior
5Y CAGR
+30.9%/yr
Recent deceleration
Acceleration
-54.7pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $26.42M | +15.8% |
| 2024 | $22.82M | +44.3% |
| 2023 | $15.81M | -47.4% |
| 2022 | $30.08M | +25.5% |
| 2021 | $23.97M | +248.2% |
| 2020 | $6.88M | -28.9% |
| 2019 | $9.67M | +64.9% |
| 2018 | $5.87M | +89.2% |
| 2017 | $3.10M | -79.0% |
| 2016 | $14.79M | - |